FastPack® IP SHBG FastPack® IP SHBG 30 ImmunoassayRecalls & reported problems
Qualigen Inc. · 30 Test SHBG Immunoassay Complete Kit w/Calibrator and Controls · Class 1
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
2 FDA recall records name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Dec 3, 2024Class IIIOpen, Classified
Three lots of the FastPacks kitted into the FastPack SHBG Complete Kits were labeled with the incorrect expiration date. The following is a listing of affected lots: Lot Number: 2408018-1, 2409015-1, and 2409015-2. The likelihood of patient harm is expected to be low as routine Quality Control should detect kits that are impacted by signal deterioration due to age.
Z-0805-2025 · Root cause: Labeling Change Control · Recall details · FDA record ↗
- Nov 6, 2019Class IITerminated
The chemiluminescent immunoassay has been noted to have higher than expected results which may result in inaccurate quantitative determinations of Sex Hormone Binding Globulin in human serum and plasma.
Z-1672-2020 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
Other Single (Specified) Analyte Controls (Assayed And Unassayed) devices
- CONTOUR® NEXT 7314Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)227 reports
- CONTOUR® NEXT 7377Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)95 reports
- ARCHITECT 7K62-25Abbott Ireland · SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED)94 reports
- ARCHITECT 08K2812Abbott GmbH · Single (specified) analyte controls (assayed and unassayed)1 recall12 reports
- CONTOUR® NEXT 9697Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)56 reports
- McKesson 5011Mckesson Medical-Surgical Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)1 recall0 reports
- HCG SERUM CONTROL KIT 138Sekisui Diagnostics, LLC · Single (specified) analyte controls (assayed and unassayed)1 recall0 reports
- ACE Control Set 1667001Sentinel Ch. SPA · Single (Specified) Analyte Controls (Assayed And Unassayed)1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page